Session on Item 3 Item 3: Policy directives to the drug programme of the United Nations Office on Drugs and Crime and strengthening the drug programme and the role of the Commission on Narcotic Drugs as its governing body, including administrative, budgetary and strategic management questions (a) Work of the United Nations Office on Drugs …
Commission will identify the notifications in the order they were received. Begin with mephedrone recommended by the UK. Then will look at ketamine recommended by China. Then will look at reocmmendations from the WHO including (a) AH-7921 should be placed in Schedule I of the 1961 Convention; (b) gamma-Butyrolactone (GBL), 1,4-butanediol, 25B-NBOMe (2C-B-NBOMe), 25C-NBOMe (2C-C-NBOMe) …
UNODC Introduction. The UNGASS provides a unique opportunity to assess what work and what doesn’t when addressing the drug problem, including in the area of alternative development. Member states clearly view alternative development as a vital pillar of any strategy. One major challenge is that starting in 2009, official development assistance for alternative development has decreased, …
I’m honoured to take the floor in preparation of the UNGASS next year. The political declaration in 2009 was a major milestone in addressing the world drug problem. Member states have tried hard to eliminate the problem by 2019. As the CND meets to prepare for the UNGASS 2016, it is apparent that while much …
Chair – Thailand: Today we hope to discuss draft resolutions and in the afternoon, scheduling. Also on the agenda are preparations for CND and the UNGASS segment next week. On the UNGASS segment, the schedule has been revised so that on Tuesday 10 March, segment B will be in the morning and segment A in …
Afternoon Session: WHO Brussels: (Video link presentation) The 36th Expert Committee took place in June. At the moment 36 substances are to be reviewed, 23 psychotropic substances and 3 therapeutic. UK asks mephredone to be scheduled 2 under the 1971 convention. China critical review of ketamine although WHO didn’t recommend any scheduling for ketamine. Director …